Aerotoxic Syndrome (ATS) is the unofficial name given to a collection of chronic health problems that some pilots, cabin crew, and passengers potentially caused by breathing air contaminated with heated engine oil and other chemicals on commercial aircraft. While not, at this time, a medically recognised diagnosis, the term, first coined in 1999, has become central to a contentious debate at the intersection of aviation, medicine, and law (Michaelis S., 2017).

The Mechanism: How Cabin Air Can Become Contaminated

Most commercial jets, with the notable exception of newer models like the Boeing 787, use a “bleed air” system. This system supplies the cabin with breathable, pressurised air by drawing it directly from the hot compressor section of the jet engines. Under normal conditions, this air is clean. However, mechanical issues like a worn-out seal can cause synthetic engine oil or hydraulic fluid to leak into the air supply.

When these fluids are heated to high temperatures, they can create a “fume event,” potentially releasing a mixture of toxic substances into the cabin. These include tricresyl phosphate, an organophosphate additive known to be a neurotoxin at high doses, carbon monoxide, and a range of volatile organic compounds. Occupants may notice a foul odour, often described as smelling like “dirty socks,” or see a visible haze in the air. While significant fume events are estimated to occur on only 0.2%–0.5% of flights, proponents of ATS argue that repeated, low-level exposures, even without obvious fumes, can cause cumulative harm over time.

Reported Health Effects: Acute and Chronic Symptoms

A primary challenge in validating Aerotoxic Syndrome is that its reported symptoms are broad and non-specific. A 2023 systematic review compiled numerous health effects reported by aircrew following fume events (Burdon J et al., 2023).

• Acute Symptoms (occurring during or shortly after a flight): These often include immediate cognitive impairment (“brain fog,” confusion), dizziness, severe headaches, nausea, tremors, and irritation of the eyes and respiratory tract. Pilots have reported temporary difficulties with coordination, raising significant flight safety concerns.
• Chronic Symptoms (developing over time with repeated exposure): The core of the ATS controversy lies in these long-term complaints. Individuals report persistent cognitive deficits like memory loss, chronic fatigue syndrome, mood disorders such as depression and anxiety, and neurological issues including tremors, balance problems, and tingling in the limbs. Chronic respiratory illnesses and gastrointestinal disturbances have also been linked to exposure.

The Scientific Divide

The scientific community is deeply split on whether Aerotoxic Syndrome is a genuine occupational disease

The Case for Aerotoxic Syndrome:

Proponents point to the consistent pattern of symptoms reported by aircrew globally. They argue that the known neurotoxicity of organophosphates provides a biologically plausible mechanism for the neurological damage claimed. Some researchers have reported finding objective biomarkers, such as chemical residues bound to proteins in blood samples of affected crew, though these tests are not widely validated. Furthermore, many affected individuals report that their symptoms improve significantly when they stop flying, suggesting a direct link between exposure and illness (Burdon J et al., 2023).

The Case Against (Scepticism and Official Stances):

Conversely, major official investigations have failed to establish a causal link. The UK’s Committee on Toxicity, after multiple comprehensive reviews, concluded that the levels of chemical contaminants measured in aircraft cabins, even during some fume events, are “unlikely to cause adverse health effects” and are far below established occupational safety limits (Committee on Toxicity, 2024).

Regulatory bodies like the U.S. Federal Aviation Administration (FAA) maintain that cabin air is safe and does not cause chronic illness, a position supported by their own research (Federal Aviation Administration, 2025). Sceptics invoke the toxicological principle that “the dose makes the poison,” arguing the exposure levels are too low to be harmful. They also highlight the lack of a definitive diagnostic test for ATS and suggest that symptoms could be explained by other factors inherent to aviation work, such as stress, disrupted sleep cycles, and mild hypoxia.

Litigation and Industry Response

The unresolved science makes legal claims for Aerotoxic Syndrome extremely challenging. Lawsuits often devolve into a “battle of the experts,” While some cases have resulted in confidential out-of-court settlements, no major public court judgment has definitively affirmed ATS as a compensable injury. A 2025 Scottish court case, for example, acknowledged the “controversial” nature of the diagnosis without dismissing it entirely, illustrating the legal ambiguity (Gough v. Cannons Law Practice, 2025).

Despite the debate, the controversy has spurred positive changes. Airlines have improved maintenance protocols to minimise fume events, and manufacturers are exploring air quality sensors and filtration systems. Critically, the development of “bleed-free” aircraft like the Boeing 787, which uses electric compressors for cabin air, eliminates the risk of oil contamination from the engines entirely.

In conclusion, Aerotoxic Syndrome remains in a scientific and legal grey area. It represents a frustrating gap between the lived experiences of sick aviation professionals and the current body of accepted scientific evidence. Until further research provides definitive answers, the issue will likely remain a cautionary tale about the difficulty of proving causation for emerging and complex occupational health concerns.

References

Committee on Toxicity. (2024). Statement on aircraft cabin air quality. UK Health Security Agency.

Federal Aviation Administration. (2025, January). Fact sheet – Cabin air quality.

Gough v. Cannons Law Practice, [2025] CSOH 28 (Court of Session, Scotland).

Burdon J, Budnik LT, Baur X, Hageman G, Howard CV, Roig J, Coxon L, Furlong CE, Gee D, Loraine T, Terry Jr AV. Health consequences of exposure to aircraft contaminated air and fume events: a narrative review and medical protocol for the investigation of exposed aircrew and passengers. Environmental Health. 2023 May 16;22(1):43.

Michaelis S., Burdon J., & Howard C.V. (2017). Aerotoxic Syndrome: A New Occupational Disease? Public Health Panorama, 3(2), 198‑211